Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0100 (25.00%)
May 14, 2026, 12:36 PM EST
Oncotelic Therapeutics Employees
As of December 31, 2025, Oncotelic Therapeutics had 43 total employees, including 38 full-time and 5 part-time employees. The number of employees increased by 13 or 43.33% compared to the previous year.
Employees
43
Change (1Y)
13
Growth (1Y)
43.33%
Revenue / Employee
n/a
Profits / Employee
$6,079,996
Market Cap
19.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 43 | 13 | 43.33% | 38 | 5 |
| Dec 31, 2024 | 30 | 8 | 36.36% | 26 | 4 |
| Dec 31, 2023 | 22 | 0 | - | 22 | 0 |
| Dec 31, 2022 | 22 | 6 | 37.50% | 22 | 0 |
| Dec 31, 2021 | 16 | 0 | - | 16 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| HOOKIPA Pharma | 87 |
| Zeo ScientifiX | 20 |
| Inhibitor Therapeutics | 8 |
| ZIVO Bioscience | 7 |
| Galera Therapeutics | 3 |
| Anebulo Pharmaceuticals | 3 |
Oncotelic Therapeutics News
- 7 hours ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform - GlobeNewsWire
- 2 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies - GlobeNewsWire
- 8 days ago - Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer's Disease - GlobeNewsWire
- 14 days ago - Oncotelic Therapeutics Advances Toward Commercial Launch of AI-Enabled Robotics Platform Following Integration of 28 Million Scientific Abstracts - GlobeNewsWire
- 20 days ago - NetworkNews Audio Announces Audio Press Release (APR) Discussing Advancing Oncology Therapeutics, Strategic Positioning within High-Value Development Pathways - GlobeNewsWire
- 20 days ago - Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy - GlobeNewsWire
- 21 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation - GlobeNewsWire
- 23 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation Evolution - GlobeNewsWire